Enviomycin

Enviomycin
Systematic (IUPAC) name
3,6-diamino-N-[(3R,6Z)-3-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • (Prescription only)
Routes of
administration
IM
Identifiers
CAS Number 33103-22-9 YesY
ATC code None
PubChem CID 3032903
DrugBank DB08993 N
ChemSpider 16736480 N
UNII XU299C23A2 YesY
KEGG D07897 YesY
ChEMBL CHEMBL2146142
Chemical data
Formula C25H43N13O10
Molar mass 685.69 g/mol
 NYesY (what is this?)  (verify)

Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus.[1] It is used in the treatment of tuberculosis.[2]

References

  1. Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732
  2. Selvakumar, N; Kumar, V; Acharyulu, GS; Rehman, F; Paramasivan, CN; Prabhakar, R (1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian journal of medical research 95: 101–4. PMID 1506058.


This article is issued from Wikipedia - version of the Wednesday, December 16, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.